Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $750K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 10SEC CRBPCorbus Pharmaceuticals Holdings, Inc. Sell Plan 17,000157,316 held (−10%) $10.08 $171K -55.2%
Feb 18SEC CRBPCorbus Pharmaceuticals Holdings, Inc. Sell Plan 13,871174,316 held (−7%) $7.78 $108K -41.9%
Oct 27SEC CRBPCorbus Pharmaceuticals Holdings, Inc. Sell Plan 18,660138,187 held (−12%) $17.01 $317K -73.4%
Oct 27SEC CRBPCorbus Pharmaceuticals Holdings, Inc. Sell Plan 8,973138,187 held (−6%) $17.14 $154K -73.6%
  • Sell

    CEO Yuval Cohen sold $171K of CRBP at $10.08 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Yuval Cohen sold $108K of CRBP at $7.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Yuval Cohen sold $317K of CRBP at $17.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Yuval Cohen sold $154K of CRBP at $17.14 — pre-scheduled 10b5-1 plan sale.